Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Feb;89(2):131–135. doi: 10.1136/adc.2002.009316

A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy

J Caulton 1, K Ward 1, C Alsop 1, G Dunn 1, J Adams 1, M Mughal 1
PMCID: PMC1719782  PMID: 14736627

Abstract

Background: Severely disabled children with cerebral palsy (CP) are prone to low trauma fractures, which are associated with reduced bone mineral density.

Aims: To determine whether participation in 50% longer periods of standing (in either upright or semi-prone standing frames) would lead to an increase in the vertebral and proximal tibial volumetric trabecular bone mineral density (vTBMD) of non-ambulant children with CP.

Methods: A heterogeneous group of 26 pre-pubertal children with CP (14 boys, 12 girls; age 4.3–10.8 years) participated in this randomised controlled trial. Subjects were matched into pairs using baseline vertebral vTBMD standard deviation scores. Children within the pairs were randomly allocated to either intervention (50% increase in the regular standing duration) or control (no increase in the regular standing duration) groups. Pre- and post-trial vertebral and proximal tibial vTBMD was measured by quantitative computed tomography (QCT).

Results: The median standing duration was 80.5% (9.5–102%) and 140.6% (108.7–152.2%) of the baseline standing duration in the control group and intervention group respectively. The mean vertebral vTBMD in the intervention group showed an increase of 8.16 mg/cm3 representing a 6% mean increase in vertebral vTBMD. No change was observed in the mean proximal tibial vTBMD.

Conclusion: A longer period of standing in non-ambulant children with CP improves vertebral but not proximal tibial vTBMD. Such an intervention might reduce the risk of vertebral fractures but is unlikely to reduce the risk of lower limb fractures in children with CP.

Full Text

The Full Text of this article is available as a PDF (293.7 KB).

Figure 1 .

Figure 1

Open in a new tab

The study design.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balena R., Toolan B. C., Shea M., Markatos A., Myers E. R., Lee S. C., Opas E. E., Seedor J. G., Klein H., Frankenfield D. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest. 1993 Dec;92(6):2577–2586. doi: 10.1172/JCI116872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brunner R., Doderlein L. Pathological fractures in patients with cerebral palsy. J Pediatr Orthop B. 1996 Fall;5(4):232–238. [PubMed] [Google Scholar]
  3. Cann C. E., Genant H. K. Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr. 1980 Aug;4(4):493–500. doi: 10.1097/00004728-198008000-00018. [DOI] [PubMed] [Google Scholar]
  4. Chad K. E., Bailey D. A., McKay H. A., Zello G. A., Snyder R. E. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr. 1999 Jul;135(1):115–117. doi: 10.1016/s0022-3476(99)70340-9. [DOI] [PubMed] [Google Scholar]
  5. De Laet C. E., Van Hout B. A., Burger H., Weel A. E., Hofman A., Pols H. A. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998 Oct;13(10):1587–1593. doi: 10.1359/jbmr.1998.13.10.1587. [DOI] [PubMed] [Google Scholar]
  6. Duncan B., Barton L. L., Lloyd J., Marks-Katz M. Dietary considerations in osteopenia in tube-fed nonambulatory children with cerebral palsy. Clin Pediatr (Phila) 1999 Mar;38(3):133–137. doi: 10.1177/000992289903800302. [DOI] [PubMed] [Google Scholar]
  7. Frost H. M. On our age-related bone loss: insights from a new paradigm. J Bone Miner Res. 1997 Oct;12(10):1539–1546. doi: 10.1359/jbmr.1997.12.10.1539. [DOI] [PubMed] [Google Scholar]
  8. Genant H. K., Engelke K., Fuerst T., Glüer C. C., Grampp S., Harris S. T., Jergas M., Lang T., Lu Y., Majumdar S. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996 Jun;11(6):707–730. doi: 10.1002/jbmr.5650110602. [DOI] [PubMed] [Google Scholar]
  9. Gilsanz V. Bone density in children: a review of the available techniques and indications. Eur J Radiol. 1998 Jan;26(2):177–182. doi: 10.1016/s0720-048x(97)00093-4. [DOI] [PubMed] [Google Scholar]
  10. Gilsanz V., Gibbens D. T., Roe T. F., Carlson M., Senac M. O., Boechat M. I., Huang H. K., Schulz E. E., Libanati C. R., Cann C. C. Vertebral bone density in children: effect of puberty. Radiology. 1988 Mar;166(3):847–850. doi: 10.1148/radiology.166.3.3340782. [DOI] [PubMed] [Google Scholar]
  11. Gilsanz V., Roe T. F., Mora S., Costin G., Goodman W. G. Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med. 1991 Dec 5;325(23):1597–1600. doi: 10.1056/NEJM199112053252302. [DOI] [PubMed] [Google Scholar]
  12. Glüer C. C., Blake G., Lu Y., Blunt B. A., Jergas M., Genant H. K. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int. 1995;5(4):262–270. doi: 10.1007/BF01774016. [DOI] [PubMed] [Google Scholar]
  13. Goulding A., Jones I. E., Taylor R. W., Manning P. J., Williams S. M. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res. 2000 Oct;15(10):2011–2018. doi: 10.1359/jbmr.2000.15.10.2011. [DOI] [PubMed] [Google Scholar]
  14. Harris S. T., Watts N. B., Genant H. K., McKeever C. D., Hangartner T., Keller M., Chesnut C. H., 3rd, Brown J., Eriksen E. F., Hoseyni M. S. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999 Oct 13;282(14):1344–1352. doi: 10.1001/jama.282.14.1344. [DOI] [PubMed] [Google Scholar]
  15. Henderson R. C. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol. 1997 Apr;39(4):224–227. doi: 10.1111/j.1469-8749.1997.tb07415.x. [DOI] [PubMed] [Google Scholar]
  16. Henderson R. C., Lin P. P., Greene W. B. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg Am. 1995 Nov;77(11):1671–1681. doi: 10.2106/00004623-199511000-00005. [DOI] [PubMed] [Google Scholar]
  17. Henderson Richard C., Lark Robert K., Kecskemethy Heidi H., Miller Freeman, Harcke H. Theodore, Bachrach Steven J. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. 2002 Nov;141(5):644–651. doi: 10.1067/mpd.2002.128207. [DOI] [PubMed] [Google Scholar]
  18. Lee J. J., Lyne E. D. Pathologic fractures in severely handicapped children and young adults. J Pediatr Orthop. 1990 Jul-Aug;10(4):497–500. [PubMed] [Google Scholar]
  19. Lingam S., Joester J. Spontaneous fractures in children and adolescents with cerebral palsy. BMJ. 1994 Jul 23;309(6949):265–265. doi: 10.1136/bmj.309.6949.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996 May 18;312(7041):1254–1259. doi: 10.1136/bmj.312.7041.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nilsson O. S., Lindholm T. S., Elmstedt E., Lindbäck A., Lindholm T. C. Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment. Arch Orthop Trauma Surg. 1986;105(3):146–149. doi: 10.1007/BF00433931. [DOI] [PubMed] [Google Scholar]
  22. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab. 2001 Oct;86(10):4576–4584. doi: 10.1210/jcem.86.10.7960. [DOI] [PubMed] [Google Scholar]
  23. Shaw N. J., White C. P., Fraser W. D., Rosenbloom L. Osteopenia in cerebral palsy. Arch Dis Child. 1994 Sep;71(3):235–238. doi: 10.1136/adc.71.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shetty A. K., Carlin J., Mughal M. Z. Urinary calcium excretion in enterally fed disabled children. Arch Dis Child. 2001 Jul;85(1):58–59. doi: 10.1136/adc.85.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stuberg W. A. Considerations related to weight-bearing programs in children with developmental disabilities. Phys Ther. 1992 Jan;72(1):35–40. doi: 10.1093/ptj/72.1.35. [DOI] [PubMed] [Google Scholar]
  26. Tasdemir H. A., Buyukavci M., Akcay F., Polat P., Yildiran A., Karakelleoglu C. Bone mineral density in children with cerebral palsy. Pediatr Int. 2001 Apr;43(2):157–160. doi: 10.1046/j.1442-200x.2001.01352.x. [DOI] [PubMed] [Google Scholar]
  27. Tolman K. G., Jubiz W., Sannella J. J., Madsen J. A., Belsey R. E., Goldsmith R. S., Freston J. W. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. Pediatrics. 1975 Jul;56(1):45–50. [PubMed] [Google Scholar]
  28. Wilmshurst S., Ward K., Adams J. E., Langton C. M., Mughal M. Z. Mobility status and bone density in cerebral palsy. Arch Dis Child. 1996 Aug;75(2):164–165. doi: 10.1136/adc.75.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES